Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of > 2 years of follow-up
Fradet, Y, Bellmunt, J, Vaughn, D J, Lee, J L, Fong, L, Vogelzang, N J, Climent, M A, Petrylak, D P, Choueiri, T K, Necchi, A, Gerritsen, W, Gurney, H, Quinn, D I, Culine, S, Sternberg, C N, Nam, K, FLanguage:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz127
Date:
May, 2019
File:
PDF, 1023 KB
english, 2019
File converter
More search results
More benefits 
